CDK1 and Alzheimer disease: Consistently, the administration of CDKIs (inhibitors of CDK1, 2, 4, 5, 7, 9) ameliorated AD symptoms in animal models [91,92,93,94,95,96], corroborating that the cell cycle and mitosis play an important role in AD development and could become important targets of drug research.